Skip to main content
CVS HEALTH Corp logo

CVS HEALTH Corp — Investor Relations & Filings

Ticker · CVS ISIN · US1266501006 LEI · 549300EJG376EN5NQE29 US Human health and social work activities
Open in API
Filings indexed 2,766 across all filing types
Latest filing 2024-12-26 Director's Dealing
Country US United States of America
Listing US CVS

About CVS HEALTH Corp

https://cvshealth.com/

CVS Health Corporation is a diversified health solutions company that provides integrated healthcare services. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a broad range of health insurance products and related services. The Health Services segment provides comprehensive pharmacy benefit management (PBM) solutions, specialty pharmacy services for complex conditions, and accessible clinical care through its network of retail health clinics and primary care centers. The Pharmacy & Consumer Wellness segment consists of its retail pharmacy chain, which dispenses prescription medications and sells a wide variety of over-the-counter health products, personal care items, and general merchandise. The company focuses on simplifying the healthcare experience and improving health outcomes by making care more accessible, affordable, and personalized.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2024-12-26 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 16, 2024, by CVS Health Corporation. It reports on the early results and pricing of a cash tender offer for certain senior notes. The content focuses on a financing activity related to debt securities, specifically a tender offer and its pricing. There are no financial statements or comprehensive financial data presented, but rather an announcement of financing activity and related press releases. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes. The document length is 6190 characters, which is sufficient to contain substantive information about the tender offer. Therefore, the appropriate classification is CAP with high confidence.
2024-12-17 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated December 10, 2024, by CVS Health Corporation. It reports the issuance and sale of subordinated notes totaling $3 billion, including details about the notes, indentures, and exhibits filed. The content focuses on a capital raising event and related financing documentation. There are no financial statements or comprehensive financial performance data typical of annual or quarterly reports. The primary subject is the company's financing activity through debt issuance. Therefore, this filing fits the category of Capital/Financing Update (CAP). The document length is 5498 characters, which is sufficient to contain substantive information about the financing event rather than just an announcement or a brief notice.
2024-12-10 English
PRIMARY DOCUMENT
Director's Dealing
2024-12-09 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 9, 2024, by CVS Health Corporation. It announces the expiration and tender results of a cash tender offer for the company's 4.100% Senior Notes due 2025. The document includes a press release as an exhibit. The content focuses on a financing activity related to debt tender offers, which is a capital/financing update. The document length is 3310 characters, which is relatively short and typical for an 8-K announcement. There is no detailed financial report or earnings data, so it is not an earnings release or interim report. The primary subject is the tender offer results, fitting the Capital/Financing Update category.
2024-12-09 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The text indicates it is reporting the pricing of a cash tender offer for senior notes, referencing a press release attached as an exhibit. The content focuses on a financing activity (tender offer pricing) rather than a full financial report or earnings release. The document length is 3288 characters, which is relatively short and primarily announces an event rather than providing detailed financial data. Therefore, this fits best under Capital/Financing Update (CAP).
2024-12-06 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.